Treating high-risk, statin-intolerant patients without a prior cardiovascular event with bempedoic acid (Nexletol; Esperion) leads to a significant reduction in their risk of atherosclerotic ...
Philadelphia, December 14, 2023 – The updated Canadian Cardiovascular Society (CCS)/Canadian Association of Interventional Cardiology (CAIC) antiplatelet therapy guidelines for primary and secondary ...
A risk calculator that incorporates established cardiovascular risk factors and additional cardiac biomarkers, such as high-sensitivity C-reactive protein (hs-CRP) and N-terminal pro-B-type ...
FRIDAY, Jan. 24, 2025 (HealthDay News) -- Among older adults and adults with low atherosclerotic cardiovascular disease (ASCVD) risk for whom aspirin is not recommended, use of aspirin decreased after ...
Analysis of the applicability of the mHealth ALIBIRD platform and its impact on the follow-up of patients with lung cancer.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The U.S. Preventive Services Task Force in August ...
NEW ORLEANS -- People with diabetes may be among those who still benefit from primary prevention aspirin, a large observational study suggested. In contrast with the unimpressive track record of ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback